| 000 | 01745 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250517205849.0 | ||
| 264 | 0 | _c20180829 | |
| 008 | 201808s 0 0 eng d | ||
| 022 | _a1091-6490 | ||
| 024 | 7 |
_a10.1073/pnas.1802811115 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDuBose, Amanda J | |
| 245 | 0 | 0 |
_aEverolimus rescues multiple cellular defects in laminopathy-patient fibroblasts. _h[electronic resource] |
| 260 |
_bProceedings of the National Academy of Sciences of the United States of America _c04 2018 |
||
| 300 |
_a4206-4211 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aBiomarkers |
| 650 | 0 | 4 |
_aCell Division _xdrug effects |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 |
_aCell Nucleus _xdrug effects |
| 650 | 0 | 4 |
_aCellular Senescence _xdrug effects |
| 650 | 0 | 4 |
_aEverolimus _xpharmacology |
| 650 | 0 | 4 |
_aFibroblasts _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLamin Type A _xdeficiency |
| 650 | 0 | 4 |
_aMuscular Dystrophy, Emery-Dreifuss _xgenetics |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 |
_aPhosphorylation _xdrug effects |
| 650 | 0 | 4 |
_aProgeria _xgenetics |
| 650 | 0 | 4 |
_aProtein Processing, Post-Translational _xdrug effects |
| 650 | 0 | 4 |
_aRibosomal Protein S6 _xmetabolism |
| 650 | 0 | 4 |
_aTOR Serine-Threonine Kinases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aWerner Syndrome _xgenetics |
| 700 | 1 | _aLichtenstein, Stephen T | |
| 700 | 1 | _aPetrash, Noreen M | |
| 700 | 1 | _aErdos, Michael R | |
| 700 | 1 | _aGordon, Leslie B | |
| 700 | 1 | _aCollins, Francis S | |
| 773 | 0 |
_tProceedings of the National Academy of Sciences of the United States of America _gvol. 115 _gno. 16 _gp. 4206-4211 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1073/pnas.1802811115 _zAvailable from publisher's website |
| 999 |
_c28220185 _d28220185 |
||